Dosing

Missed a few weeks of Wegovy, Zepbound, Ozempic, Trulicity, Saxenda, or a GLP-1 pill? Only four labels spell out when to restart at a lower dose: Wegovy injection after 2 missed weekly doses, Saxenda and Victoza after more than 3 days, and Foundayo after 7 missed daily doses. The rest are silent on long gaps. This by-drug reference separates what each label says from what's left to your prescriber, and explains why going straight back to your old dose is risky.

If you've lost weight on Zepbound or Wegovy and want off the weekly injection, can a daily pill hold your results? One randomized trial has now tested exactly that, and Wegovy users also have an on-label switch to Wegovy tablets. This guide covers what the trial found, how much weight people kept, what the switch felt like, and the big question the trial didn't answer.

Some people space their weekly GLP-1 to every 10 or 14 days to save money or ease off. This guide covers what that does to drug levels, what the two small studies found, why that isn't proof yet, and the risks worth planning around with a prescriber.

Liraglutide (Victoza for diabetes, Saxenda for weight) was the first GLP-1 approved for weight management. It's a daily injection with a half-life of about 13 hours and generally more modest weight loss than the weekly drugs. What makes it different, and why some people still choose it.

Every GLP-1 injection ends with a needle you have to put somewhere. This guide walks through the FDA's two-step system: a proper sharps container (or an acceptable heavy-duty household stand-in), the short list of things never to do with a used needle, how to find your community's disposal rules, and what changes when you travel.

On a U-100 insulin syringe, "units" measure volume: 100 units make 1 mL. Your vial's concentration is what turns a prescribed mg dose into a unit count. This walkthrough teaches the arithmetic with worked examples at different concentrations, explains the dosing errors the FDA has documented, and gives a checklist to go through with your pharmacist. It teaches you to read the syringe. It does not prescribe doses.

Whether by choice or circumstance, most people stop a GLP-1 at some point. This guide covers what stopping can and can't get you, what withdrawal trials and real-world data show about weight regain and lost health benefits, whether a GLP-1 is really a medication for life, how tapering compares, and why restarting after a gap usually means re-titrating.

Once-weekly dosing turns "shot day" into a small ritual. People build routines around it: picking the right day, warming the pen to reduce sting, rotating sites, eating lighter, logging everything, and heading off side effects before they start. This is a tour of the common routines GLP-1 users swear by, and the reasons behind the ones worth copying.

"Microdosing" GLP-1s is all over social media: using much smaller doses than the label calls for, for weight maintenance, side-effect avoidance, cost, or vague wellness claims. What the term means, the real medicine it borrows from, why no clinical trial has tested it, the specific risks of the DIY version, and how to have a lower-dose conversation with your prescriber instead.

The pen in your fridge is the product of a century of injection-device development. How GLP-1 delivery devices evolved, which brands use vials, multi-dose pens or single-dose auto-injectors, why pens are easier and safer than vials, and how auto-injectors differ from dial-a-dose pens.

The GLP-1 drug class is 20 years old. It began with a twice-daily injection derived from Gila monster venom. This timeline lists every U.S.-approved GLP-1 drug and its maker, which ones are no longer sold, how they compare, and what's still in the pipeline.

Long-term GLP-1 treatment doesn't have to mean staying at your highest effective dose indefinitely. This guide compares tapering to a lower maintenance dose with stopping altogether or holding steady.

A weight loss plateau doesn't automatically mean you need a higher dose, and a higher dose doesn't automatically break a plateau. How dose and weight loss relate, including the new 7.2 mg Wegovy dose, and what else to check first.

You can stay at a dose step longer than the standard titration schedule says. This guide covers what the labels allow, the common reasons prescribers extend a step, and how to raise it.

Brand-name GLP-1 pens measure the dose for you. Compounded versions usually come as a vial and syringes, so you measure it yourself. Why that raises the stakes on accuracy, what to ask your pharmacy, and where compounding stands after the shortages ended.

Refrigeration rules, room-temperature windows, and flying with an injectable medication all raise practical questions. This guide gives the label storage windows for each GLP-1 pen and pill, a few habits that protect your medication, and what to plan before a trip.

Not all GLP-1 pens work the same way. Some are pre-set single-dose auto-injectors; others need a needle attached, a dose set, and a priming step. A brand-by-brand comparison and the technique habits that apply to every pen.

Ozempic and Wegovy share an active ingredient, as do Mounjaro and Zepbound, but switching between them isn't always a straight swap. Semaglutide's two dose ladders split after 1 mg; tirzepatide's ladder is identical, but the label and coverage still change.

Staying below the maximum labeled dose isn't a compromise or a sign of "not trying hard enough." For many people it's the clinically appropriate outcome. The reasons, and what the trials show about lower doses.

Injecting twice, or using the wrong-strength pen, does happen. What to expect in the days after, when to call your prescriber or Poison Help, and how to keep it from happening again.

Missed-dose rules depend on how close you are to your next scheduled dose and on the drug, and getting it wrong in either direction carries real risk. The label rules for weekly injections, daily injections and pills, and when a missed dose means restarting lower.

Your maintenance dose is the dose that works for you, which isn't always the highest dose on the label. This guide explains how that dose gets chosen, what the trials show about higher and lower maintenance doses, and when it can change.

Semaglutide, tirzepatide, dulaglutide, liraglutide and orforglipron each have their own titration ladder, with different starting doses, step sizes and timing. A side-by-side table of the injections and pills, and why you should confirm your own schedule with your prescriber.

GLP-1 doses don't start at their effective target. They climb in deliberate steps. Why titration is structured this way, what it means for side effects, why you re-titrate after a break, and what the labels allow if the pace feels too fast.